taurine has been researched along with Disease, Pulmonary in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acute pancreatitis was induced by administering three subcutaneous injections of cerulein (40 microg/kg body weight) at 1-hour intervals, while taurine was administered intravenously at graded doses (30, 100, or 300 mg/kg, respectively) following the first cerulein injection." | 5.31 | Effects of taurine on cerulein-induced acute pancreatitis in the rat. ( Ahn, BO; Hyun, JH; Kim, CD; Kim, KH; Kim, WB; Kim, YS; Lee, G; Lee, HS; Oh, TY; Son, MW, 2001) |
| "Human inhalation exposures to relatively high mass concentrations of the oxidant gas nitrogen dioxide (NO2) can result in a variety of pulmonary disorders, including life-threatening pulmonary edema, pneumonia, and bronchiolitis obliterans." | 3.69 | Lung injury following exposure of rats to relatively high mass concentrations of nitrogen dioxide. ( Archuleta, DC; Ellis, T; Gurley, LR; Lehnert, BE; Lehnert, NM; Session, WS; Stavert, DM, 1994) |
| " This formulation could improve the bioavailability of macromolecule drugs without any serious local damage to the lungs." | 1.46 | Arachidonic acid with taurine enhances pulmonary absorption of macromolecules without any serious histopathological damages. ( Emoto, C; Minami, T; Miyake, M; Mukai, T; Toguchi, H; Yamazaki, H, 2017) |
| "Treatment with taurine and niacin attenuated the BL-induced increases in proinflammatory cytokines such as IL-1alpha, TNF-alpha, IL-6, and TGF-beta in BALF and lung hydroxyproline content of the mice in BL + TN groups." | 1.31 | Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice. ( Giri, SN; Gurujeyalakshmi, G; Wang, Y, 2000) |
| "Acute pancreatitis was induced by administering three subcutaneous injections of cerulein (40 microg/kg body weight) at 1-hour intervals, while taurine was administered intravenously at graded doses (30, 100, or 300 mg/kg, respectively) following the first cerulein injection." | 1.31 | Effects of taurine on cerulein-induced acute pancreatitis in the rat. ( Ahn, BO; Hyun, JH; Kim, CD; Kim, KH; Kim, WB; Kim, YS; Lee, G; Lee, HS; Oh, TY; Son, MW, 2001) |
| "Taurine acts as a trap for toxic hypochlorous acid (HOCl) and forms the less reactive metabolite, N-chlorotaurine (5-6)." | 1.29 | Taurine protects against oxidant-induced lung injury: possible mechanism(s) of action. ( Park, E; Quinn, MR; Schuller-Levis, G; Wright, C, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jafari, M | 1 |
| Solhi, E | 1 |
| Tagi, S | 1 |
| Hasanzadeh, M | 1 |
| Jouyban-Gharamaleki, V | 1 |
| Jouyban, A | 1 |
| Shadjou, N | 1 |
| Miyake, M | 1 |
| Minami, T | 1 |
| Yamazaki, H | 1 |
| Emoto, C | 1 |
| Mukai, T | 1 |
| Toguchi, H | 1 |
| Marti, MC | 1 |
| Moser, G | 1 |
| Wicki, O | 1 |
| Linder, M | 1 |
| del Ponte, F | 1 |
| Schuller-Levis, G | 1 |
| Quinn, MR | 1 |
| Wright, C | 1 |
| Park, E | 1 |
| Venkatesan, N | 1 |
| Chandrakasan, G | 1 |
| Covarrubias, J | 1 |
| Lehnert, BE | 1 |
| Archuleta, DC | 1 |
| Ellis, T | 1 |
| Session, WS | 1 |
| Lehnert, NM | 1 |
| Gurley, LR | 1 |
| Stavert, DM | 1 |
| Gurujeyalakshmi, G | 1 |
| Wang, Y | 1 |
| Giri, SN | 1 |
| Ahn, BO | 1 |
| Kim, KH | 1 |
| Lee, G | 1 |
| Lee, HS | 1 |
| Kim, CD | 1 |
| Kim, YS | 1 |
| Son, MW | 1 |
| Kim, WB | 1 |
| Oh, TY | 1 |
| Hyun, JH | 1 |
| Gordon, RE | 1 |
| Heller, RF | 2 |
1 review available for taurine and Disease, Pulmonary
| Article | Year |
|---|---|
Taurine and the lung: pharmacological intervention by aerosol route.
Topics: Administration, Inhalation; Aerosols; Animals; Female; Humans; Lung Diseases; Male; Oxidants; Rats; | 1994 |
9 other studies available for taurine and Disease, Pulmonary
| Article | Year |
|---|---|
Non-invasive quantification of malondialdehyde biomarker in human exhaled breath condensate using self-assembled organic-inorganic nanohybrid: A new platform for early diagnosis of lung disease.
Topics: Biocompatible Materials; Biomarkers; Breath Tests; Carbon; Early Diagnosis; Electrochemical Techniqu | 2019 |
Arachidonic acid with taurine enhances pulmonary absorption of macromolecules without any serious histopathological damages.
Topics: Animals; Arachidonic Acid; Area Under Curve; Biological Availability; Bronchitis; Drug Compounding; | 2017 |
[Intravenous and intraperitoneal administration of an antiseptic: 65 cases of diffuse peritonitis treated with taurolin].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Female; Humans; Injections, Intraperitoneal; Injecti | 1980 |
Taurine protects against oxidant-induced lung injury: possible mechanism(s) of action.
Topics: Amino Acid Oxidoreductases; Animals; Cells, Cultured; Female; Kinetics; Lung Diseases; Nitric Oxide; | 1994 |
In vivo administration of taurine and niacin modulate cyclophosphamide-induced lung injury.
Topics: Acid Phosphatase; Alkaline Phosphatase; Amino Acid Sequence; Animals; Ascorbic Acid; Bronchoalveolar | 1994 |
Lung injury following exposure of rats to relatively high mass concentrations of nitrogen dioxide.
Topics: Administration, Inhalation; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Lung | 1994 |
Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice.
Topics: Animals; Anti-Bacterial Agents; Bleomycin; Blotting, Western; Bronchoalveolar Lavage Fluid; Down-Reg | 2000 |
Effects of taurine on cerulein-induced acute pancreatitis in the rat.
Topics: Acute Disease; Amylases; Animals; Ceruletide; Disease Models, Animal; Interleukin-1; Lung Diseases; | 2001 |
Taurine protection of lungs in hamster models of oxidant injury: a morphologic time study of paraquat and bleomycin treatment.
Topics: Animals; Antioxidants; Bleomycin; Cricetinae; Diet; Disease Models, Animal; Fresh Water; Lung Diseas | 1992 |